Health Care & Life Sciences » Pharmaceuticals | Valeant Pharmaceuticals International Inc.

Valeant Pharmaceuticals International Inc. | Mutual Funds

Mutual Funds that own Valeant Pharmaceuticals International Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
4,849,501
1.39%
57,021
0.03%
07/31/2018
Legg Mason Opportunity Trust
3,600,000
1.03%
3,600,000
4.5%
12/31/2016
DFA International Core Equity Portfolio
2,703,915
0.77%
0
0.23%
04/30/2018
Vanguard Developed Markets Index Fund
1,926,477
0.55%
-1,600
0.04%
07/31/2018
iShares S&P/TSX 60 Index ETF
1,838,606
0.53%
-32,412
0.55%
09/06/2018
Fidelity Canadian Growth Company Fund
1,811,873
0.52%
240,424
1.01%
07/31/2018
British Columbia Inv Management Corp.
1,634,880
0.47%
-259,448
0.04%
03/31/2017
ClearBridge Aggressive Growth Fund
1,507,645
0.43%
-6,902
0.28%
12/31/2017
DFA International Value Series
1,493,777
0.43%
163,616
0.28%
01/31/2018
Canada Pension Plan
1,390,000
0.4%
1,390,000
0.01%
03/31/2018

About Valeant Pharmaceuticals International

View Profile
Address
2150 St. Elzéar Boulevard West
Laval Québec H7L 4A8
Canada
Employees -
Website http://www.bauschhealth.com
Updated 07/08/2019
Bausch Health Cos. , Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Branded Rx, and U.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.